REFRACTORY AML

Clinical trials for REFRACTORY AML explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY AML trials appear

Sign up with your email to follow new studies for REFRACTORY AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New cell therapy combo tested for Tough-to-Treat blood cancer

Disease control Ongoing

This is an early-phase safety study testing a new combination treatment for adults with acute myeloid leukemia (AML) that has returned or not responded to standard therapies. The treatment involves a single infusion of genetically modified immune cells (CART123) given after a sho…

Matched conditions: REFRACTORY AML

Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control

Last updated Apr 01, 2026 23:41 UTC

REFRACTORY AML

Get alerted when new REFRACTORY AML trials appear

New cell therapy combo tested for Tough-to-Treat blood cancer